文献速递膀胱癌与上尿路尿路上皮癌

根治性与部分性膀胱切除术治疗肌层浸润性膀胱癌的成本比较

Comparing Costs of Radical Versus Partial Cystectomy for Patients Diagnosed With Localized Muscle-Invasive Bladder Cancer: Understanding the Value of Surgical Care.
PubMed 文献 · Urology · 2020-09-24

本研究纳入2305例66-85岁临床T2-4a肌层浸润性膀胱癌患者,比较根治性与部分性膀胱切除术后1年内 Medicare 总成本。结果显示两者中位总成本无显著差异,但部分性膀胱切除的癌症特异性生存更差(HR 1.45),支持根治性膀胱切除为高价值手术。

要点

  • 根治性与部分性膀胱切除术后90、180、365天中位总成本无显著差异。
  • 部分性膀胱切除的癌症特异性生存显著差于根治性膀胱切除(HR 1.45)。
  • 两者总生存相似,但根治性膀胱切除的肿瘤学价值更高。

核心结论

  • 根治性膀胱切除与部分性膀胱切除的总成本相当,但部分性膀胱切除的癌症特异性生存更差。

研究设计与样本

  • 采用逆概率处理加权倾向评分模型比较根治性与部分性膀胱切除后1年内 Medicare 总成本。
  • 使用 Cox 回归和竞争风险分析分别评估总生存和癌症特异性生存。

主要发现

  • 90天中位总成本根治性 vs 部分性为 $73,907 vs $65,721,中位差异 $16,796(95% CI $10,038-$23,558)。
  • 180天中位总成本为 $113,288 vs $82,840,中位差异 $36,369(95% CI $25,744-$47,392)。
  • 365天中位总成本为 $143,831 vs $107,359,中位差异 $34,628(95% CI $17,819-$53,558)。
  • 住院、手术、病理/实验室、药房和 skilled nursing facility 成本是两种治疗成本的主要构成。
  • 部分性膀胱切除患者总生存相似,但癌症特异性生存更差(HR 1.45,95% CI 1.34-1.58,P < .001)。

临床怎么用

  • 对于肌层浸润性膀胱癌,根治性膀胱切除在成本相当的情况下提供更好的癌症特异性生存,应作为高价值手术选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare costs associated with radical versus partial cystectomy. Prior studies noted substantial costs associated with radical cystectomy, however, they lack surgical comparison to partial cystectomy. METHODS: A total of 2305 patients aged 66-85 years diagnosed with clinical stage T2-4a muscle-invasive bladder cancer from January 1, 2002 to December 31, 2011 were included. Total Medicare costs within 1 year of diagnosis following radical versus partial cystectomy were compared using inverse probability of treatment-weighted propensity score models. Cox regression and competing risks analysis were used to determine overall and cancer-specific survival, respectively. RESULTS: Median total costs were not significantly different for radical than partial cystectomy in 90 days ($73,907 vs $65,721; median difference $16,796, 95% CI $10,038-$23,558), 180 days ($113,288 vs $82,840; median difference $36,369, 95% CI $25,744-$47,392), and 365 days ($143,831 vs $107,359; median difference $34,628, 95% CI $17,819-$53,558), respectively. Hospitalization, surgery, pathology/laboratory, pharmacy, and skilled nursing facility costs contributed largely to costs associated with either treatment. Patients who underwent partial cystectomy had similar overall survival but had worse cancer-specific survival (Hazard Ratio 1.45, 95% Confidence Interval, 1.34-1.58, P < .001) than patients who underwent radical cystectomy. CONCLUSION: While treatments for bladder cancer are associated with substantial costs, we showed radical cystectomy had comparable total costs when compared to partial cystectomy among patients with muscle-invasive bladder cancer. However, partial cystectomy resulted in worse cancer-specific survival further supporting radical cystectomy as a high-value surgical procedure for muscle-invasive bladder cancer.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Bagheri I, Shan Y, Klaassen Z, et al. Comparing Costs of Radical Versus Partial Cystectomy for Patients Diagnosed With Localized Muscle-Invasive Bladder Cancer: Understanding the Value of Surgical Care. Urology. 2020. PMID: 32980405. doi:10.1016/j.urology.2020.08.058

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。